Table 2.
Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|
Variables | HR | 95% CI | P value | HR | 95% CI | P value | |
Age | |||||||
> 65 vs ≤ 65 years | 0.81 | 0.59-1.12 | 0.198 | ||||
Gender | |||||||
Male vs Female | 0.91 | 0.66-1.25 | 0.568 | ||||
Tumor site | |||||||
Rectum vs Colon | 0.95 | 0.68-1.32 | 0.738 | ||||
Tumor size | |||||||
≥ 5 vs < 5 cm | 1.54 | 1.11-2.12 | 0.009 | 1.33 | 0.95-1.86 | 0.096 | |
Histological subtype | |||||||
Adenocarcinoma vs others | 0.88 | 0.47-1.61 | 0.670 | ||||
Histological grage | |||||||
Poor vs Well/Moderate | 1.73 | 1.24-2.41 | 0.001 | 1.53 | 1.08-2.17 | 0.016 | |
Depth of tumor invasion | |||||||
T3+T4 vs T1+T2 | 2.56 | 1.70-3.87 | <0.001 | 1.65 | 1.07-2.56 | 0.024 | |
Lymph node metastasis | |||||||
Presence vs Adsence | 2.90 | 2.10-4.00 | <0.001 | 1.78 | 1.24-2.57 | 0.002 | |
Distant metastasis | |||||||
Presence vs Adsence | 6.79 | 4.77-9.67 | <0.001 | 4.31 | 2.91-6.38 | <0.001 | |
Serum CEA level | |||||||
≥ 10 vs < 10 ng/mL | 1.50 | 1.07-2.10 | 0.019 | 1.30 | 0.91-1.86 | 0.144 | |
GHRLOS expression | |||||||
Decreased vs Non-decreased | 2.20 | 1.57-3.09 | <0.001 | 2.02 | 1.42-2.88 | <0.001 |
HR, hazard ratio; CI, confidence interval; CEA, carcinoembryonic antigen.